Therapeutic Peptides Expanded 2 intermediate
Semorinemab: Oligopeptide Research Reference
Semorinemab, a bioactive peptide compound with documented applications in biomedical research, pharmacological studies, and therapeutic development
By Encyclopeptide Editorial | 1 min read
therapeutic-peptides-expanded-2 peptide oligopeptide
Overview
Semorinemab is a bioactive peptide with well-characterized properties and therapeutic applications.
Structure
| Property | Value |
|---|---|
| Name | Semorinemab |
| Sequence | Humanized IgG4 monoclonal antibody targeting N-terminal region of tau protein |
| Length | ~1325 amino acids |
| Molecular Weight | ~147 kDa |
| Category | Neurology / Anti-Tau Antibody |
Mechanism of Action
Binds tau protein (mid-region epitope, residues 6–23), inhibiting tau aggregation and reducing tau spreading between neurons (anti-seed antibody)
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Test Your Knowledge
Reinforce what you learned about Semorinemab: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept